REGENERON PHARMACEUTICALS, INC. Related Party Transaction, Revenues from Transactions with Related Party (Deprecated 2012-01-31)
REGENERON PHARMACEUTICALS, INC. (REGN) reported Related Party Transaction, Revenues from Transactions with Related Party (Deprecated 2012-01-31) of $145.04 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-10-24.
Discontinued › Income Statement › Other Income
us-gaap:RelatedPartyTransactionRevenuesFromTransactionsWithRelatedParty · last filed 2012-10-24
- REGENERON PHARMACEUTICALS, INC. related party transaction, revenues from transactions with related party (deprecated 2012-01-31) for the quarter ending 2012-09-30 was $145.04M, a 81.75% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. related party transaction, revenues from transactions with related party (deprecated 2012-01-31) for the quarter ending 2012-06-30 was $88.99M, a 5.38% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. related party transaction, revenues from transactions with related party (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $85.00M, a 0.38% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. related party transaction, revenues from transactions with related party (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $77.03M, a 6.22% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. related party transaction, revenues from transactions with related party (deprecated 2012-01-31) for fiscal 2011 was $326.61M, a 4.91% increase from fiscal 2010.
- REGENERON PHARMACEUTICALS, INC. related party transaction, revenues from transactions with related party (deprecated 2012-01-31) for fiscal 2010 was $311.33M, a 25.97% increase from fiscal 2009.
- REGENERON PHARMACEUTICALS, INC. related party transaction, revenues from transactions with related party (deprecated 2012-01-31) for fiscal 2009 was $247.14M.
| Period end | Related Party Transaction, Revenues from Transactions with Related Party (Deprecated 2012-01-31) 3 month | Related Party Transaction, Revenues from Transactions with Related Party (Deprecated 2012-01-31) 6 month | Related Party Transaction, Revenues from Transactions with Related Party (Deprecated 2012-01-31) 9 month | Related Party Transaction, Revenues from Transactions with Related Party (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-09-30 | $145.04M 10-Q · filed 2012-10-24 | $234.03M derived: sum of 2 quarters · filed 2012-10-24 | $319.04M 10-Q · filed 2012-10-24 | $396.07M derived: sum of 4 quarters · filed 2012-10-24 |
| 2012-06-30 | $88.99M 10-Q · filed 2012-07-25 | $173.99M 10-Q · filed 2012-07-25 | $251.03M derived: sum of 3 quarters · filed 2012-07-25 | $330.83M derived: sum of 4 quarters · filed 2012-10-24 |
| 2012-03-31 | $85.00M 10-Q · filed 2012-04-26 | $162.04M derived: sum of 2 quarters · filed 2012-04-26 | $241.84M derived: sum of 3 quarters · filed 2012-10-24 | $326.29M derived: sum of 4 quarters · filed 2012-10-24 |
| 2011-12-31 | $77.03M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $156.83M derived: sum of 2 quarters · filed 2012-10-24 | $241.28M derived: sum of 3 quarters · filed 2012-10-24 | $326.61M 10-K · filed 2012-02-21 |
| 2011-09-30 | $79.80M 10-Q · filed 2012-10-24 | $164.25M derived: sum of 2 quarters · filed 2012-10-24 | $249.58M 10-Q · filed 2012-10-24 | $331.71M derived: sum of 4 quarters · filed 2012-10-24 |
| 2011-06-30 | $84.45M 10-Q · filed 2012-07-25 | $169.78M 10-Q · filed 2012-07-25 | $251.91M derived: sum of 3 quarters · filed 2012-07-25 | $327.50M derived: sum of 4 quarters · filed 2012-07-25 |
| 2011-03-31 | $85.33M 10-Q · filed 2012-04-26 | $167.47M derived: sum of 2 quarters · filed 2012-04-26 | $243.05M derived: sum of 3 quarters · filed 2012-04-26 | $327.99M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $82.14M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $157.72M derived: sum of 2 quarters · filed 2012-02-21 | $242.66M derived: sum of 3 quarters · filed 2012-02-21 | $311.33M 10-K · filed 2012-02-21 |
| 2010-09-30 | $75.58M 10-Q · filed 2011-10-27 | $160.52M derived: sum of 2 quarters · filed 2011-10-27 | $229.19M 10-Q · filed 2011-10-27 | |
| 2010-06-30 | $84.94M 10-Q · filed 2011-07-28 | $153.61M 10-Q · filed 2011-07-28 | ||
| 2009-12-31 | $247.14M 10-K · filed 2012-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |